IGC Pharma, Inc.
IGC
$0.30
-$0.03-9.37%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.06% | 32.76% | 58.51% | 67.28% | 29.95% |
| Total Depreciation and Amortization | -17.93% | -12.96% | -6.10% | -1.88% | -8.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -183.76% | 6.47% | 16.89% | -90.22% | -29.58% |
| Change in Net Operating Assets | -133.51% | -708.06% | -117.68% | 50.00% | 51.61% |
| Cash from Operations | -109.84% | 19.69% | -38.78% | 17.01% | 38.44% |
| Capital Expenditure | 0.00% | 78.95% | -20.00% | 60.29% | 17.14% |
| Sale of Property, Plant, and Equipment | -243.75% | -- | 1,100.00% | -- | 1,700.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -519.23% | -22.58% | 52.26% | -1,200.00% | -148.15% |
| Cash from Investing | -475.38% | 542.75% | 56.04% | -70.49% | -190.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | -- | 0.00% | 0.00% |
| Issuance of Common Stock | 291.32% | -66.03% | 20.69% | -- | -72.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 291.69% | -66.06% | 20.69% | 34,600.00% | -72.23% |
| Foreign Exchange rate Adjustments | 145.45% | 1,150.00% | 0.00% | -100.00% | -10.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 334.17% | -92.17% | 63.89% | 34.71% | -121.34% |